Select Page
Garrett D. Pohlman, MD

Garrett D. Pohlman, MD

Kearney Urology Center, P.C.

Kearney, Nebraska

Dr. Pohlman is a urologist with Kearney Urology Center, P.C., in Kearney, Nebraska. He received his undergraduate degree from the University of Nebraska, Lincoln, and his medical degree from the University of Nebraska College of Medicine in Omaha. He then went on to complete his internship and residency at the University of Colorado School of Medicine in Denver. Dr. Pohlman specializes in urinary incontinence, bladder diseases, and other urinary disorders. Dr. Pohlman is also the host of the Prostate Health Podcast. On it, he conducts weekly interviews with experts, innovators, and leaders regarding prostate conditions. With the podcast, he is educating the general public regarding prostate health, the conditions that affect the prostate, and the latest technology used to manage these conditions. The podcast can be found at www.prostatehealthpodcast.com.

Disclosures:

Talks by Garrett D. Pohlman, MD

Optilume

Optilume

Posted by | Oct 2024

Garrett D. Pohlman, MD, discusses the Optilume BPH procedure, a novel treatment for benign prostatic hyperplasia (BPH). In this 11-minute talk, Pullman gives step-by-step instructions for the Optilume placement procedure, emphasizing how the treatment can be tailored to individual patients based on prostate size, anatomy, and personal preferences.

Pullman discusses the safety and efficacy of Optilume, as well as data from studies like Pinnacle and Everest. He also shares that the placement procedure can be performed in various settings, including outpatient surgery centers and offices. He asserts that Optilume BPH is a promising, durable, and patient-friendly option for treating BPH.

Read More
EpiSwitch® Prostate Screening (PSE) Blood Test

EpiSwitch® Prostate Screening (PSE) Blood Test

Posted by | Sep 2024

Garrett D. Pohlman, MD, discusses his experience with the EpiSwitch® Prostate Screening (PSE) Blood Test in his practice. This presentation was supported by Oxford BioDynamics. He begins with a brief overview of the weaknesses of PSA tests alone in determining if further testing (i.e. prostate biopsy, etc.) is indicated or not.

Dr. Pohlman then brings up emerging complementary tests that mitigate the weaknesses of PSA alone, like the EpiSwitch® Prostate Screening (PSE) Blood Test. He explains that the EpiSwitch® PSE combines five epigenetic biomarkers with a standard PSA test in prostate cancer screening. He briefly discusses how the simplified test can be implemented in practice and how the test results are quickly and clearly delivered in patient-friendly formats to facilitate shared decision-making.

Dr. Pohlman then discusses the validation processes behind the EpiSwitch® PSE test, including its high accuracy, specificity, sensitivity, and positive/negative predictive values, which reduce the need for unnecessary prostate biopsies. He presents data supporting the benefits of using non-invasive biomarker tests like the EpiSwitch® PSE test in prostate cancer screening prior to MRI and/or prostate biopsy.

Dr. Pohlman concludes by presenting case studies where the EpiSwitch® PSE test would have prevented unnecessary biopsies and MRIs. He discusses his practice’s success in using the EpiSwitch® PSE tests to screen for prostate cancer without defaulting to invasive testing.

Read More
Optilume® BPH Catheter System: Surgical Procedure and BPH Patient Management

Optilume® BPH Catheter System: Surgical Procedure and BPH Patient Management

Posted by | Aug 2024

E. David Crawford, MD, Dean S. Elterman, MD, MSC, FRCSC, and Garrett D. Pohlman, MD, explore the practical functionality of the Optilume® BPH Catheter System, a novel minimally-invasive surgical therapy (MIST). This is the third in a series supported by Laborie.

Dr. Elterman begins with a step-by-step demonstration of the Optilume® BPH Catheter System’s surgical procedure. For each step, he provides his perspective on best practices during the procedure.

Dr. Pohlman then discusses the management of BPH patients and the patient’s perspective on what successful treatment looks like. He addresses pretreatment guidance and counseling for BPH patients who are eligible for the Optilume® BPH Catheter System, i.e., patients looking for a minimally-invasive BPH treatment without the need for medication.

Dr. Crawford concludes by asking Dr. Elterman and Dr. Pohlman for their perspectives on patient and physician reception of the Optilume® BPH Catheter System in their practices. Dr. Pohlman discusses his experiences with reimbursement, significant flow improvement, and options for balloon sizing. Dr. Elterman discusses the durability of patient QoL improvement, limited catheter time, and sexual function preservation.

To see the first part of this series, click here. To see the second part of this series, click here.

Read More
Panel Discussion on Integration of Stakeholders in Healthcare: The Small Group Practice Experience

Panel Discussion on Integration of Stakeholders in Healthcare: The Small Group Practice Experience

Posted by | May 2020

Garrett D. Pohlman, MD, a urologist with Kearney Urology Center, P.C., discusses the importance of collaboration and collegiality among small group practice urologists. He highlights the benefits of integrated care to urologists and the ways small group providers can stay connected, noting how both of these approaches ultimately improve patient care. Dr. Pohlman concludes by describing the launch of a new prostate health podcast targeted at the general public and intended to provide education on a variety of urology topics.

Read More
Telemedicine Strategies for Urology Practices to Cope with the COVID-19 Outbreak

Telemedicine Strategies for Urology Practices to Cope with the COVID-19 Outbreak

Posted by | Mar 2020

Garrett D. Pohlman, MD, a urologist with Kearney Urology Center, P.C., discusses telemedicine strategies for urology practices to help them cope with the COVID-19 crisis. Telemedicine has been recommended by the CDC as part of the COVID-19 response, and federal regulations have been relaxed in order to broaden access. Dr. Pohlman recommends checking with both malpractice insurance as well as the different payers to ensure that telemedicine is covered before incorporating it into practice. He also recommends several platforms that doctors can quickly integrate into their practice and explains how they work. He highlights how easy they are to use for the patients and for the doctors, as well as some essential differences, specific requirements, and limitations of the telemedicine platforms. Finally, he highly recommends the benefits of being a member of a physician community where doctors can support each other and discuss how to get through these difficult times.

Read More

Join the GRU Community

- Why Join? -